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Inhibition of Akt Signaling by Exclusion from
Lipid Rafts in Normal and Transformed Epidermal
Keratinocytes
Damien Calay1,2, Dina Vind-Kezunovic1, Aurelie Frankart1, Sylviane Lambert2, Yves Poumay2 and
Robert Gniadecki1
Lipid rafts are cholesterol-rich plasma membrane domains that regulate signal transduction. Because our earlier
work indicated that raft disruption inhibited proliferation and caused cell death, we investigated here the role
of membrane cholesterol, the crucial raft constituent, in the regulation of the phosphatidylinositol-3 kinase
(PI3K)/Akt pathway. Raft disruption was achieved in normal human keratinocytes and precancerous (HaCaT) or
transformed (A431) keratinocytes by cholesterol extraction or inactivation with methyl-b-cyclodextrin, filipin III,
or 5-cholestene-5-b-ol. Lipid raft disruption did not affect PI3K binding to its main target, the epidermal growth
factor receptor, nor its ability to convert phosphatidylinositol 4,5-bisphosphate to phosphatidylinositol 3,4,5-
trisphosphate but impaired Akt phosphorylation at the regulatory sites Thr308 and Ser473. Diminished Akt activity
resulted in deactivation of mammalian target of rapamycin, activation of FoxO3a, and increased sensitivity
to apoptosis stimuli. Lipid raft disruption abrogated the binding of Akt and the major Akt kinase,
phosphatidylinositol-dependent kinase 1, to the membrane by pleckstrin-homology domains. Thus, the
integrity of lipid rafts is required for the activity of Akt and cell survival and may serve as a potential
pharmacological target in the treatment of epidermal cancers.
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INTRODUCTION
The plasma membrane contains nanometer-large dynamic
microdomains enriched in cholesterol, sphingolipids, and
gangliosides called ‘‘lipid rafts’’. These structures are impor-
tant regulators of signal transduction (Simons and Ikonen,
1997). Because lipid rafts form spontaneously only in the
narrow range of cholesterol concentration, the perturbation
of membrane cholesterol disrupts lipid raft integrity and
has been used extensively to study their role in signaling
pathways. In our previous studies, we have documented
that in keratinocytes lipid rafts can aggregate into larger
structures that retard lateral mobility of the molecules (Vind-
Kezunovic et al., 2008b) and influence membrane geometry
(Vind-Kezunovic et al., 2008a). Rafts influence the enzymatic
activity of several membrane-associated proteins, including
the epidermal growth factor receptor (EGFR), insulin growth
factor receptor (IGFR), or Fas (Simons and Toomre, 2000;
Hueber et al., 2002). Depletion of cholesterol by methyl-
b-cyclodextrin (MBCD) in keratinocytes leads to a ligand-
independent, transient activation of EGFR, cell-cycle block,
apoptosis, and Fas activation (Gniadecki, 2004; Bang et al.,
2005; Lambert et al., 2006).
Several studies have shown that Akt/protein kinase B is
a cardinal regulator of cell survival and its pathological
increase in activity causes carcinogenesis (Datta et al., 1999;
Shaw and Cantley, 2006). Membrane receptors including the
ErbB family of surface receptors, IGFRs, or Ras stimulate Akt
kinase activity by the phosphatidylinositol 3-kinase (PI3K)
(Rodriguez-Viciana et al., 1994; Burgering and Coffer, 1995).
PI3K catalyzes the conversion of membrane phosphatidyl-
inositol 4,5-bisphosphate (PI(4,5)P2) to phosphatidylinositol
3,4,5-trisphosphate (PI(3,4,5)P3), to which both Akt and its
immediate activator phosphatidylinositol-dependent kinase 1
(PDK-1) bind by pleckstrin-homology (PH) domains (Harlan
et al., 1994; McManus et al., 2004). Full activation of
Akt requires phosphorylation of Thr308 by PDK-1, followed
by a second phosphorylation at Ser473 (Alessi et al., 1997).
Downstream components of the Akt/PI3K signaling cascade
include mammalian target of rapamycin (mTOR)/p70S6K
pathway (Burnett et al., 1998; Nave et al., 1999) and the
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apoptosis-related Forkhead family of transcription factors
FoxO, causing their emigration from the nucleus (Bonni et al.,
1999; Greer and Brunet, 2005).
Lipid rafts are known to be enriched in PI(4,5)P2 and
PI(3,4,5)P3 (Hope and Pike, 1996) and are therefore likely
to provide the particularly permissive milieu for the inter-
action between PDK-1 and Akt. Recent fluorescent resonance
energy transfer-based and fluorescence correlation spectro-
scopy-based studies revealed that Akt is more effectively
activated when located in lipid raft-like regions (Gao and
Zhang, 2008; Lasserre et al., 2008). We have therefore
hypothesized that raft disruption could cause the loss or
redistribution of phosphoinositol species in the membrane
and affect the membrane targeting binding of PH-domain
proteins. Because the dependency of Akt activity of lipid
rafts is dependent on both cell type and the nature of the
activatory stimulus (Gao and Zhang, 2008), we focused in
this study on normal, immortalized, and transformed
keratinocytes. This is the first study to provide evidence
that Akt colocalizes with the detergent-resistant, lipid raft-
like regions of the membrane in keratinocytes and that lipid
raft disruption by cholesterol depletion causes rapid Akt
inactivation and increases keratinocytes susceptibility to
apoptosis.
RESULTS
MBCD depletes membrane cholesterol and induces an abrupt
dephosphorylation of Akt, inactivation of mTOR, and nuclear
export of FoxO3a
HaCaT cells were treated for different times with MBCD,
a water-soluble heptasaccharide that binds cholesterol with
high affinity (Ohtani et al., 1989). Our previous data, as well
as results shown in Figure 1a, documented the efficacy of
MBCD for cholesterol removal in epidermal cells. HaCaT cells
contain an elevated basal level of Akt activity in comparison
with the nontransformed primary keratinocytes and are
therefore especially suitable for Akt inhibition studies
(unpublished data). As shown in Figure 1b, treatment with
1% MBCD reduced Akt phosphorylation at its regulatory sites
(Thr308 and Ser473). Phosphorylation levels could be restored in
the cells in which cholesterol was repleted (Figure 1c).
Of note, the levels of total Akt decreased in cells treated
for 43hours with MBCD that could be caused by proteolytic
degradation of Akt molecules by macroautophagy. Disruption
of lipid rafts results in the caspase-independent,
autophagic cell death (Poster no. 87, European Life Scientist
Organization (ELSO) Meeting, Dresden, Germany; http://
www.elso.org/index.php?id=abstrlist2005&lid=334). Levels
of phosphorylated mTOR, its downstream target p70S6K, and
FoxO3a were decreased in response to cholesterol depletion
(Figure 1b) and were reversed by cholesterol repletion.
The reduced phosphorylation of p70S6K was only observed
at the Thr389 residue, which is mTOR specific. Accordingly,
Akt-dependent translocation of FoxO3a from the nucleus
to the cytoplasm was blocked in MBCD-treated cells, resulting
in an increased nuclear immunoreactivity of FoxO3a
(Figure 1d) and enrichment of nuclear fractions in FoxO3a
protein (Figure 1e).
The loss of Akt activity due to cholesterol depletion was not
specific to HaCaT keratinocytes but was also seen in non-
transformed normal keratinocytes (Figure 1g) and in the human
squamous cell carcinoma line A431 (Figure 1f). Treatment
with 1% of MBCD caused also a redistribution of FoxO3a
similarly to what was seen in HaCaT cells (Figure 1d).
To eliminate the possibility that MBCD treatment affected
Akt by other mechanisms than cholesterol depletion, we
decreased membrane cholesterol levels by simvastatin, used
a specific cholesterol binding agent filipin III (Schnitzer et al.,
1994), and destabilized lipid rafts with 5-cholesten-5-b-ol.
As shown in Figure 1h, all agents were able with different
efficacies to decrease the phosphorylation of Akt and Thr389
p70S6K. Together with the cholesterol repletion experiment
(Figure 1c), the data strongly indicate that the decrease in the
activity of Akt and its downstream target proteins are due to
cholesterol depletion.
PI3K activity is not affected by cholesterol depletion
Dephosphorylation of Akt and inactivation of mTOR/p70S6K
and FoxO3a similar to that observed after MBCD treatment
could also be induced by the PI3K inhibitors, wortmannin
and LY294002 (Figure 1b). We have therefore hypothesized
that cholesterol depletion caused PI3K inactivation. In HaCaT
keratinocytes the activity of EGFR is the main determinant of
PI3K activity (Figure 2a and unpublished data). However,
EGFR is activated rather than inactivated by cholesterol
depletion in HaCaT keratinocytes (Lambert et al., 2006). In
accordance with that finding, the binding of the p85
regulatory subunit of PI3K to the EGFR was increased, rather
than decreased in cholesterol depleted cells (Figure 2b,c),
except for the cells that were treated for 5minutes, in which
the p85/EGFR ratio was the same as in DMEM-treated
control. To evaluate whether the cholesterol depletion
could alter PI3K activity without affecting its binding to
EGFR, we measured the PI3K activity directly in cell extracts.
In agreement with the immunoprecipitation results, no reduc-
tion in the PI3K activity was detected after treatment with
MBCD in HaCaT cells (Figure 2d), although a slight decrease
occurred in A431 cells after 60minutes treatment (not
shown).
Cholesterol depletion induces nuclear translocation of PDK-1
Because the observed changes in Akt activity could not be
explained by inactivation of PI3K, we investigated whether
activity of PDK-1 is affected by lipid raft integrity. The activity
of PDK-1 is regulated by activatory phosphorylation at Ser241;
however, as shown in Figure 3a the amount of PDK-1-P-
Ser241 in control and MBCD-treated cells was equal, or even
slightly increased after 15 and 30minutes of MBCD. Another
regulatory mechanism, described recently, is the redistri-
bution of PDK-1 from membrane to the nucleus. The cyto-
plasmic-nuclear shuttling of PDK-1 is independent of Ser241
phosphorylation status and PDK-1 retains kinase activity
within the nucleus (Lim et al., 2003). After 15minutes of
MBCD to induce cholesterol depletion in HaCaT keratino-
cytes, we observed an enhanced nuclear accumulation of
PDK-1 (Figure 3b–d).
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PI3K, PDK-1, and Akt are excluded from lipid rafts after
cholesterol depletion
The nuclear relocalization of PDK-1 raised the possibility that
Akt hypophosphorylation on Thr308 could result from PDK-1
sequestration outside the enzymatic reaction site in the
membrane. If PDK-1-dependent phosphorylation of Akt takes
place within the rafts, cholesterol depletion should initially
result in the release of both proteins to the nonraft
compartment. To investigate whether this takes place, we
used approaches based on confocal imaging of PI(3,4,5)P3
and PI(4,5)P2 in HaCaT cells or on the analysis of partitioning
of PI3K, PDK-1, and Akt to nonraft heavy fractions and raft-
enriched light fractions of the membranes separated accord-
ing to their buoyant densities. In preliminary experiments, we
determined that raft markers, caveolin-1 and flotillin-2, were
indeed predominantly detected in light fractions 3 and 4 but
partitioned to the heavy fractions in MBCD-treated cells
(Figure 4h and data not shown). In control cells, cross-linking
of the raft component, the GM1 ganglioside, caused form-
ation of raft clusters resolvable on confocal images as
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Figure 1. Cholesterol depletion induces dephosphorylation of Akt, mammalian target of rapamycin (mTOR), and translocation of FoxO3a to the nucleus.
(a) Serum-starved HaCaT cells were treated with methyl-b-cyclodextrin (MBCD) for 15minutes at indicated concentrations followed by 5 mM cholesterol for
a total of 1 hour (solid bars) or serum-free DMEM (open bars). Cholesterol concentration in plasma membrane was determined by cholesterol oxidase Amplex
red assay as described in Materials and Methods. Data are mean values (n¼ 6 experiments) with SD and represent percentage of the negative control
(cells treated only with DMEM). (b) Serum-starved HaCaT cells were pretreated with a vehicle (control) or with phosphatidylinositol-3 kinase (PI3K) inhibitors
LY294002 (20mM) or wortmannin (0.5 mM) for 30minutes at 37 1C before incubation with 1% MBCD in serum-free DMEM for the indicated times at 37 1C.
Whole-cell lysates were resolved by SDS–PAGE and immunoblotted with antibodies directed against P-Ser473 Akt, P-Thr308 Akt, P-mTOR, P-Thr389 p70S6K,
P-Thr421/Ser424 p70S6K, P-FoxO3a, total Akt, and actin (loading control). (c) HaCaT cells were cholesterol depleted with 1% MBCD for 15minutes and then
repleted with 5 mM cholesterol (or left in DMEM for control) for an additional 45minutes, as in a. Phosphorylation of Akt, mTOR, and FoxO3a was determined
as in b. (d and e) Translocation of FoxO3a to the nucleus in MBCD-treated cells. HaCaT or A431 cells were incubated with LY294002 (20mM), wortmannin
(0.5 mM), Akt inhibitor X (5 mM) or 1% MBCD or left untreated for 30minutes at 37 1C. Cells were fixed in acetone at 4 1C, rehydrated in phosphate-buffered
saline/BSA (0.5%, 15minutes) and stained with rabbit anti-FoxO3a followed by labeling with secondary Alexa Fluor 488 antibody (both at 4 1C for 30minutes).
Nuclei were counterstained with propidium iodide, outlined, and the FoxO3a-specific fluorescence was determined in the nuclear (black bars) and cytoplasmic
(white bars) areas by image analysis of confocal images (d). *Po0.05, t-test against control. (e) Nuclear and cytoplasmic fractions from HaCaT cells were
prepared as in Materials and Methods and immunoblotted with antibodies against total FoxO3 and actin. (f and g) Influence of MBCD on Akt/mTOR
pathway in A431 cells (f) and normal human keratinocytes (g). Western blots were performed as in b. (h) HaCaT cells were incubated with simvastatin
(20mM, overnight), filipin III (2 mM, 1 hour), cholesterol oxidase (Chol. ox., 1Uml1, 1 h), 5-cholesten-5-b-ol (5-chol, 5 mM, 2 hours), or with DMSO (vehicle)
at 37 1C. Cell lysates were subjected to SDS–PAGE and immunoblotted with the antibodies indicated above.
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CTxbright clusters on the basal, glass-facing portion of the
membrane (Figure 4a,c) and on the apical membranes
(Figure 4b,d). Immunoreactivities for PI(3,4,5)P3 and
PI(4,5,)P2 colocalized with the CTxbright regions. However,
this colocalization was lost in the MBCD-treated cells
and phosphoinositol staining in these cells was very weak
(Figure 4e). Raft cross-linking with the antibody against
flotillin 2, an independent raft marker, caused a different
pattern comprising formation of smaller, globular domains on
the surface of the membrane. Also in this case, flotillin 2 and
PI(4,5)P2 and PI(3,4,5)P3 immunoreactivities overlapped in
control cells, but not in MBCD-treated cells (Figure 4f,g).
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Figure 2. The downregulation of Akt is not due to reduced phosphatidylinositol-3 kinase (PI3K) activity in cholesterol-deprived HaCaT cells. (a) Serum-starved
HaCaT cells were pretreated with vehicle (control), epidermal growth factor receptor (EGFR) inhibitor tyrphostin AG1478 (1 mM), or the PI3K inhibitor
LY294002 (20mM) for 15minutes, 37 1C. Subsequently, cells were incubated in the presence or absence of 1% MBCD for an additional 15minutes at 37 1C.
Cell lysates were subjected to SDS–PAGE followed by western blotting for P-Ser473 Akt, P-Thr308 Akt, P-Thr389 p70S6K, and P-Thr421/Ser424 p70S6K. Actin
immunoblotting was used as loading control. (b) HaCaT cells were treated with or without 1% methyl-b-cyclodextrin (MBCD) in serum-free medium for
the indicated times at 37 1C. Cells were lysed, immunoprecipitated with anti-p85 antibodies, and the precipitates resolved by SDS–PAGE and probed with
anti-EGFR antibody and anti-p85 PI3K. The actin immunoreactivity was determined in whole-cell lysates to ensure equal amount of total cellular protein
for immunoprecipitation. (c) Quantification of the ratio of p85 and coimmunoprecipitated EGFR measured from the western blot data (n¼ 3 independent
experiments). Cells were treated with DMEM for 5–60minutes (negative control, graph shows 15-minute value), 10 ngml1 EGF for 5minutes (positive control),
or were incubated for the indicated times with 1–2% MBCD. *Po0.05 comparing to the negative control, t-test. (d) HaCaT cells were treated as indicated,
immunoprecipitation was performed as described in b, and the immune complexes were assayed for their ability to phosphorylate PI(4,5)P2 as a substrate
at room temperature during 3 hours. The PI(3,4,5)P3 production was measured by a PI(3,4,5)P3 detector. The PI(3,4,5)P3 production data after treatment
with MBCD are depicted as percentages of control (cells incubated in DMEM). *Po0.05 comparing to the control, t-test.
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Figure 3. Phosphatidylinositol-dependent kinase 1 (PDK-1) translocates to the nucleus and retains kinase activity in methyl-b-cyclodextrin (MBCD)-treated
cells. (a) Serum-starved HaCaT cells were treated with or without 1% MBCD for the indicated times at 37 1C. Cell lysates were resolved by SDS–PAGE
and immunoblotted with antibody to P-PDK-1. (b) Confocal images showing the localization of PDK-1 in serum-starved HaCaT cells incubated in the
presence or absence of 1% MBCD for 15minutes at 37 1C. After fixation, cells were stained with murine anti-PDK-1 antibody followed by the Alexa Fluor
488-conjugated secondary antibody. (c) Cells were treated with 1% MBCD for 15minutes as in b. Nuclear and cytoplasmic fractions from the cells were
prepared as in Materials and Methods and immunoblotted with antibodies against total PDK-1 and actin. (d) Quantification of fluorescence from representative
images of cells treated as in b. FU, fluorescence units; n¼ 20 cells, means with SD.
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Membrane flotation experiment revealed that PI3K, PDK-1,
and Akt were enriched in light fractions, but relocated toward
heavy fractions in MBCD-treated cells (Figure 4h). In view of
the studies from our laboratory and others (Chen and Resh,
2002) that EGFR is associated with rafts in intact cells, we
have considered the possibility that lipid rafts form the
nanoscale reaction chambers facilitating the interaction of
EGFR, PI3K, PDK-1, and Akt. Because lipid rafts are enriched
in phosphoinositides (Hope and Pike, 1996) and both PDK-1
and Akt contain the phosphoinositide-binding PH domains,
we determined membrane binding by PH domains in
cholesterol-depleted cells.
Inhibition of membrane binding by PH domains in
MBCD-treated cells
We used PH domains fused to green fluorescent proteins
(GFP) to determine the ability of PH domains to bind to the
membrane in living cells. We performed transient transfec-
tions in normal keratinocytes and HaCaT cells with Akt-PH-
GFP plasmid and phospholipase C (PLC)d-PH-GFP wild-type
(WT) and mutant (MT) constructs (Balla and Varnai, 2002).
The PLCd-PH-GFPMT has a mutated inactivated phosphatidyl-
inositol-interacting residue R40L. Both Akt and PLCd WT
PH domains were enriched at the plasma membrane in
control cells, but redistributed to intracellular localization
after MBCD treatment. This redistribution was rapid and
was observable within 5minutes of MBCD treatment and
remained stable over the observation time of 30minutes.
By contrast, the inactivated PLCd-PH-GFP (MT) remained
uniformly distributed throughout the cytoplasm and nucleus
without any detectable alteration in fluorescence intensity
after MBCD treatment (Figure 5).
Akt inhibition by cholesterol depletion sensitizes the cells
to death ligand TRAIL and chemotherapeutic agents etoposid
and doxorubicin
The PI3K/Akt signaling pathway is essential in promoting
cellular survival (Datta et al., 1999) and has an important role
counteracting the pro-apoptotic activity of tumor necrosis
factor-related apoptosis inducer ligand (Chen et al., 2001;
Thakkar et al., 2001) and chemotherapeutic agents (He et al.,
2006). Therefore, we considered the possibility that the
inhibitory effect of cholesterol depletion on Akt could
enhance TNF-related apoptosis-inducing ligand (TRAIL)-
induced apoptosis. As shown in Figure 6, treatment of HaCaT
keratinocytes or A431 cells with the apoptosis inducer TRAIL
in combination with MBCD, PI3K inhibitors (wortmannin or
LY294002), and specific Akt blocker (Akt inhibitor X) resulted
in an increased cell death in comparison to treatment with
TRAIL alone. The sensitivity of cells to TRAIL in MBCD-
treated cells was not further enhanced by PI3K inhibitors,
further suggesting that Akt blockade was the primary
mechanism after cholesterol depletion and lipid raft disrup-
tion. Similar phenomena were observed for etoposid
and doxorubicin (Figure 6c–f). The notion that apoptosis
was responsible for the observed increased cell death
was confirmed by measurements of the effector caspase 3/7
activity (Figure 6g).
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Figure 4. Cholesterol depletion abrogates the association of PI3K, Akt, and
PDK-1 with lipid rafts. (a–g) Confocal images of the cells showing
colocalization of PIP3 (a, b, e) and PIP2 (c, d, f, g) with lipid raft markers:
GM1 ganglioside (stained with cholera toxin B subunit, CTx; a–e) or flotillin 2
(f, g). Control cells (a–d and f) or cells treated for 15minutes with 1% methyl-
b-cyclodextrin (MBCD) (e, g) were preincubated with CTx-Alexa 555
conjugate or anti-flotillin 2 antibody to cross-link lipid rafts. The cells were
then fixed in paraformaldehyde, permeabilized in Triton X-100, and
incubated with anti-PIP2 or anti-PIP3 antibodies followed by the Alexa 488-
conjugated secondary antibodies. Colocalization of markers is reflected by
yellow color, black and white images correspond to the individual
fluorescence channels, red (R) or green (G). Bar¼ 10mm. (h) Serum-starved
HaCaT cells were treated in the presence or absence of 1% MBCD for
15minutes at 37 1C. Subsequently cell lysates were subjected to sucrose
density gradient centrifugation. Gradients were fractionated and subjected to
SDS–PAGE followed by western blotting with antibodies to caveolin-1, p85
subunit of PI3K, total Akt, or PDK-1. Flotation fractions showing enrichment
in the raft marker caveolin 1 (i.e., fractions 3 and 4 in our experiments) were
designated as raft fractions.
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DISCUSSION
The present data indicate that in normal, premalignant, and
malignant keratinocytes disruption of cholesterol-enriched
lipid rafts in plasma membrane decreases the activity of Akt.
Cholesterol perturbation by different agents resulted in an
abrupt downregulation of Akt activity and downstream signal
transduction to mTOR/p70S6K and FoxO3a. Although similar
observations have been independently made on other cell
types, including the lymphocytes (Lasserre et al., 2008),
breast and prostate cancer cells (Li et al., 2006), and
melanoma (Fedida-Metula et al., 2008), this is the first report
to show so in normal and transformed keratinocytes and to
explain how the activity of Akt is modulated in lipid rafts.
Among different pathways leading to Akt activation
(growth factor receptor-dependent activation of PI3K and
PDK-1, the integrin-dependent Akt phosphorylation by FAK,
and the phosphorylation by nonreceptor kinases Fyn and Src
recruited to the E-cadherin-b-/g-catenin complex at cell–cell
junctions (Calautti et al., 2005)), the EGFR/PI3K axis has a
dominant role in keratinocytes. However, cholesterol deple-
tion does not cause inactivation of EGFR and did not affect its
association with PI3K. Instead, we propose that raft disruption
eliminates the phosphoinositide-enriched sites in the mem-
brane to which Akt and PDK-1 bind by PH domains.
We envisage lipid rafts as reaction nanochambers allow-
ing proximity and enzymatic interaction between PDK-1 and
Akt. This notion is based on the finding of the copurification
of detergent-resistant membrane fractions with Akt. This type
of colocalization is not universally found; in most cells Akt
is able to reside both inside and outside the rafts and in
some cases even preferentially homes to nonraft membrane
component (Adam et al., 2007; Arcaro et al., 2007; Gao and
Zhang, 2008). Localization of Akt in the rafts may make the
keratinocytes particularly sensitive to cholesterol depletion.
Cholesterol perturbation causes disruption or dispersion of
lipid rafts and movement of the EGFR/PI3K complexes into
the more fluid, nonraft areas of the membrane (see also data
in Figure 4). In spite of the fact that the activity of PI3K in the
cholesterol depleted cells is unchanged, the PI(3,4,5)P3
produced by this enzyme is probably dispersed in the
membrane instead of being concentrated in the highly orga-
nized raft nanodomains. It is also possible that PI(3,4,5)P3 is
preferentially produced in raft regions like shown for the
insulin-like growth factor-1 in fibroblasts (Gao and Zhang,
2008). As a consequence, the binding of PH-domain proteins,
such as Akt, PLCd, and PDK-1, to the membrane can be
impaired (data in Figure 5), which precludes their spatial
interaction and Akt phosphorylation. PDK-1 being unable to
dock to the membrane is translocated into the nucleus
(Figure 3).
Our results open new venues to the pharmacological
inhibition of Akt activity. Akt in keratinocytes constitutes
a dominant survival pathway and its blockade leads to
apoptotic and autophagic cell death, even in the presence of
an active EGFR/ERK axis. The PI3K/Akt/mTOR pathway is
hyperactivated in many types of cancer providing survival
advantage to transformed cells (Altomare and Testa, 2005)
often due to inactivatory mutations in the gene coding
phosphatase and tensin homologue deleted on chromosome
ten lipid phosphatase mediating dephosphorylation of
PI(3,4,5)P3 to PI(4,5)P2. The data presented in this study
indicate that cholesterol depletion and Akt inhibition lowers
the threshold of sensitivity to death receptor ligands, such as
TRAIL, and other chemotherapeutic agents, such as etoposid
and doxorubicin. Thus, cholesterol depletion may be a
promising method for increasing chemosensitivity to the
cytostatics in patients with malignant tumors. Preliminary
observations on high-dose statins support this notion
(Kornblau et al., 2007).
MATERIALS AND METHODS
Reagents and antibodies
MBCD, cholesterol, water-soluble cholesterol, tyrphostin
AG1478, cholesterol oxidase, filipin III, adenosine 50-triphosphate,
doxorubicin and etoposide, and DMSO were purchased
from Sigma-Aldrich (St Louis, MO). Simvastatin, LY294002, Akt
inhibitor X (10-(4-(N-diethylamino)butyl)-2-chlorophenoxazine, HCl),
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Figure 5. Methyl-b-cyclodextrin (MBCD) induces dissociation of Akt-PH-
GFP and PLC-PH-GFP (WT) from the plasma membrane. The cells were
transfected with plasmids containing Akt-PH-GFP, PLCd-PH-GFP(WT),
and PLCd-PH-GFP (MT). Cells were left untreated or treated with 1% MBCD
for 0–30minutes at 37 1C and imaged at room temperature in the phenol
red-free DMEM. Control cells were treated with MBCD-free media in
identical conditions. Line intensity histograms were obtained from the
horizontal cross-sectional images (as marked on the image above) and
fluorescence intensity was measured within the membrane (Akt-PHm,
PLC-PH(WT)m, PLC-PH(MT)m) and cytoplasmic regions (Akt-PHc,
PLC-PH(WT)c, PLC-PH(MT)c) in 50 randomly selected cells. The results of
these measurements are shown as mean values in arbitrary fluorescence
units with standard deviations (n¼ 50). Open bars, control cells; hatched
bars, MBCD-treated cells. *Po0.05 in comparison to the control (t-test).
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and wortmannin were from Calbiochem (La Jolla, CA) and
5-cholestene-5-b-ol was from Steraloids (Newport, RI). Antibodies
were purchased from Cell Signaling (Beverly, MA), except for the
anti-PI3K p85 subunit (Upstate, Lake Placid, NY); anti-PDK-1 and anti-
flotillin 1 (Santa Cruz Biotechnology, Santa Cruz, CA); anti-PI(3,4,5)P3
and anti-PI(4,5)P2 (Echelon Biosciences, Salt Lake City, UT).
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Figure 6. Cholesterol depletion sensitizes HaCaT and A431 cells to the cytotoxic effect of death ligand tumor necrosis factor-related apoptosis-inducing
ligand (TRAIL), etoposid, and doxorubicin. (a–f) HaCaT cells (a, c, e) or A431 cells (b, d, f) were cholesterol-depleted for 15minutes with 1% methyl-b-
cyclodextrin (MBCD) and cultured in the presence of different concentrations of TRAIL, etoposid, or doxorubicin for 24 hours, alone or in combination
with Akt inhibitors: LY294002 (20mM) or Akt inhibitor X (5 mM). To eliminate MBCD-induced toxicity, we removed this compound after total 3 hours incubation.
The number of cells was determined by the methylene blue assay. Shown are means with SD. *Po0.05, t-test. (g) HaCaT cells were treated as above
and apoptosis was determined after 24 hours using the caspase 3/7 assay as described in Materials and Methods. The following concentrations of apoptosis
inducers were used: 5 ngml1 TRAIL, 20 mM etoposid, and 1 mgml1 doxorubicin.
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The apoptosis inducer Killer TRAIL was from Alexis Biochemicals
(San Diego, CA). All other chemicals were obtained from Sigma-
Aldrich unless indicated otherwise. Sterols were prepared as
1,000 solutions in ethanol.
Cell culture, cholesterol depletion, and repletion
HaCaT cell line, a spontaneously immortalized, nontumorigenic cell
line derived from human keratinocytes (Boukamp et al., 1988) was
originally obtained from Dr MR Pittelkow (Mayo Clinic, Rochester,
MI). The human epidermoid carcinoma A431 cell line was from
the ATCC (Manassas, VA). Cells were maintained in DMEM
(Gibco-BRL, Paisley, UK), supplemented with 10% of fetal calf
serum (Gibco-BRL), at 37 1C in a humidified incubator containing
5% CO2. Normal human adult keratinocytes isolated from samples
obtained after plastic surgery were seeded into 30mm Petri dishes at
7 103 cells per cm2 in complete medium (EpiLife containing
HKGS; Cascade Biologics, Portland, OR). When cells were
approximately 50% confluent, medium was replaced by autocrine
growth medium (EpiLife without HKGS) and cells were allowed to
reach confluence as described by Jans et al. (2004). For cholesterol
depletion, the cells were washed in phosphate-buffered saline (PBS)
and incubated in serum-free culture media with the indicated
concentrations of MBCD, filipin III, simvastatin, or 5-cholestene-5-b-
ol. Cholesterol was repleted by incubation with as 5 mM water-
soluble cholesterol in DMEM or by cholesterol–cyclodextrin com-
plexes as described by Powers et al (2006). In the second method,
after the depletion step with MBCD, the cells were washed with PBS
and incubated in the absence or presence of cholesterol (Sigma-
Aldrich; 80 mgml1)/1.5mM MBCD complexes at 37 1C for 15min-
utes to replete with cholesterol. Repletion was confirmed by the
measurement of total membrane cholesterol (see below).
Western blotting
Cells were grown in 60mm Petri dishes and allowed to reach 80%
confluence. Cells were washed twice with PBS and lysed in 200ml of
sample buffer (0.5 M Tris-HCl (pH 6.8), 5% glycerol, 10% SDS, 0.2 M
DTT). Protein concentration was determined in each sample using
the DC reagent (Bio-Rad Laboratories, Hercules, CA) as described by
the manufacturer. Total cellular protein (50–100 mg) was separated
by SDS–PAGE on 10% gels and electrotransferred onto a nitro-
cellulose membrane (Bio-Rad Laboratories). The membrane was
incubated 1 hours at 4 1C with Li-Cor blocking agent (Lincoln, NE)
before incubation with either primary mouse or rabbit antibody
overnight at 4 1C. Secondary antibodies labeled with 700IR Dye
(anti-mouse) and 800IR Dye (anti-rabbit) (both obtained from Li-Cor)
were used for the detection with the infrared Odyssey imaging
System (Li-Cor).
Immunoprecipitation
HaCaT cells were seeded in 60mm Petri dishes and allowed to reach
80% confluence before treatment. Cells were then rinsed once with
ice-cold PBS and lysed in 500ml of RIPA buffer (PBS with 1%
Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, complete
protease inhibitor (Roche Applied Science, Indianapolis, IN),
1mM phenylmethylsulfonyl fluoride, 1mM Na3VO4, 50mM NaF)
for 10minutes at 4 1C. Cells were disrupted by repeated aspiration
through a 21-gauge needle, and lysates were transferred to a 1.5ml
centrifuge tube. Cellular debris were pelleted by centrifugation at
10,000 r.p.m. for 10minutes at 4 1C and the protein concentration of
the resulting supernatants was determined using the Bio-Rad DC
reagent. PI3K was precipitated with 5ml of anti-PI3K p85 subunit
antibody overnight at 4 1C with continuous rotation followed by
protein G-sepharose (Sigma-Aldrich) for 1 hour at 4 1C. Immunocom-
plexes were collected by centrifugation for 5 seconds at 14,000g at
4 1C, washed three times with ice-cold RIPA buffer, resuspended in
60ml of electrophoresis sample buffer, and boiled for 5minutes. The
supernatant was analyzed by western blotting, as described above.
PI3K activity
PI3K activity was measured using the PI3 Kinase ELISA kit from
Echelon Biosciences following the instructions of the manufacturer.
PI3K was isolated from HaCaT or A431 cells by immunoprecipita-
tion as described above and incubated in the presence of ATP
and PI(4,5)P2 for 3 hours at room temperature, followed by the
PI(3,4,5)P3 detector for 1 hour at room temperature. Reactions were
stopped by addition of 0.5M H2SO4 and absorbance was measured
at 450 nm.
Membrane cholesterol content
The cholesterol oxidase-Amplex red assay was used using the
commercially available kit (Molecular Probes, Portland, OR)
according to manufacturer’s protocol. Briefly, HaCaT cells were
seeded in 24-well plate (120,000 cells per well) and grown for 1 day
in DMEM with 10% of fetal calf serum. After the treatment, the cells
were washed once with PBS and scraped with the Amplex Red kit
buffer. The samples were centrifuged for 10minutes to pellet the
cells and membranes. The concentration of H2O2, produced by
cholesterol oxidase, was measured in the supernatants by the
Amplex red reagent. Cholesterol concentration was determined from
the standard curve and adjusted to the total protein concentration in
the sample.
DNA constructs and transient transfections
Akt-PH-GFP and PLCd-PH-GFP (wild-type and R40 L mutant) were
originally created by Dr Tamas Balla (National Institute of Child
Health and Human Development, National Institutes of Health,
Bethesda, MD) (Varnai and Balla, 1998; Balla and Varnai, 2002).
NHK were transiently transfected using FuGENE 6 (Roche Applied
Science) as recommended by the manufacturer (FuGENE/DNA ratio
3:1). For the transfection of HaCaT cells, 2-day-old cultures were
switched to DMEM and transfected using Lipofectamine LTX
(Invitrogen, Paisley, UK) according to the manufacturer’s protocol.
Living cells in phenol-free DMEM medium were imaged using a
Leica (Wetzlar, Germany) TCS NT/SP confocal microscope at room
temperature using the 488 nm line of an argon laser with a  63 oil
objective. The emission was recorded at 510–555 nm. For each
series of experiments, the photomultiplier gain remained unchanged.
Confocal laser scanning microscopy
Cells grown on Lab-Tek chamber slides (Nunc, Roskilde, Denmark)
were fixed at 4 1C in either 4% paraformaldehyde for 20minutes
followed by 10minutes permeabilization in 0.1% Triton X-100 or
in acetone for 10minutes. Cells were rehydrated in PBS with 0.5%
BSA (PBS/BSA) for 15minutes, incubated with the primary rabbit
or mouse antibody for 30minutes at 4 1C, washed twice with PBS,
and subsequently labeled with Texas Red anti-rabbit antibody
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(Jackson Laboratories, Bar Harbor, ME) or Alexa 488-conjugated
anti-mouse antibody (Molecular Probes) antibody for 30minutes at
4 1C. For double stainings, cholera toxin B subunit (CTx) conjugated
with Alexa Fluor 555 (Molecular Probes) was used. The samples
were imaged on an Olympus IX70 confocal laser-scanning micro-
scope using the 488 and 568nm excitation lines from an argon/
krypton laser (FluoView Confocal System; Olympus, Tokyo, Japan).
Background, nonspecific fluorescence level was determined in
samples stained with secondary antibody only. The fluorescence
intensity was determined using the proprietary FluoView software in
minimum 20 cells for each experiment.
Subcellular fractionation
Cells cultured to 80% confluence in 100mm Petri dishes were
rinsed twice with ice-cold PBS, once with DEB (10mM Tris-HCl
(pH 7.5), 150mM NaCl) and scraped in 1ml of TEB (DEB þ 1%
Triton X-100 and complete protease inhibitor (Roche Applied
Science)). Cell lysates were homogenized by repeated aspiration
through 23-gauge needles and cleared by centrifugation at 5,000g.
The pellet was used for the subsequent purification of the nuclei
using the Nuclei Isolation EZ Kit (Sigma-Aldrich). The supernatants
were either used as cytoplasmic fractions or further processed for the
purification of detergent resistant membranes. For the latter, 1ml of
the lysates were adjusted to 40% sucrose and placed at the bottom of
an ultracentrifuge tube. A sucrose gradient (30 and 5% in DEB) was
then layered and the samples were centrifuged at 39,000 r.p.m. in a
Beckman Coulter (Brea, CA) Optima L-80 XP Ultracentrifuge using
an SW41 rotor for 18 hours at 2 1C. Fractions of 1.25ml were
collected, diluted in DEB, and subjected to a 41,000 r.p.m.
centrifugation using the SW41 rotor for 1 hours at 4 1C. Pellets were
recovered and boiled in electrophoresis sample buffer for western
blotting.
Cell survival and apoptosis
Cells were seeded on 24-well plates at 100,000 cells per well and
allowed to adhere overnight before the treatment. The cells were
incubated for 24 hours as indicated, washed twice in PBS, and fixed
in 4% buffered paraformaldehyde and stained with 0.1% aqueous
methylene blue for 15minutes. The dye was subsequently extracted
with 0.1 M HCl and absorbance was detected at 595 nm (Ultraspec III
spectrophotometer; Pharmacia, Uppsala, Sweden). For apoptosis
assay, the Caspase-Glo 3/7 Assay (Promega, Madison, WI) detecting
the activity of apoptosis-specific caspase 3 and 7 was performed
according to the manufacturer’s instructions. Luminescence was
recorded using a Wallac 1420 Victor II microplate-based lumin-
ometer (PerkinElmer, Wellesley, MA).
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